🇺🇸 FDA
Pipeline program

FST201 (dexamethasone 0.1% with povidone-iodine 1%)

FST201-AOE-AS

Phase 3 small_molecule completed

Quick answer

FST201 (dexamethasone 0.1% with povidone-iodine 1%) for Acute Otitis Externa is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Acute Otitis Externa
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials